Your browser doesn't support javascript.
Asthma admission among children in Hong Kong during the first year of the COVID-19 pandemic.
Wong, K L; Wong, Wilfred H S; Yau, Y S; Lee, S L; Chiu, Susan S S.
  • Wong KL; Department of Paediatrics, Queen Elizabeth Hospital, Kowloon, Hong Kong.
  • Wong WHS; Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong.
  • Yau YS; Department of Paediatrics, Queen Elizabeth Hospital, Kowloon, Hong Kong.
  • Lee SL; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
  • Chiu SSS; Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong.
Pediatr Pulmonol ; 57(12): 3104-3110, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2027396
ABSTRACT

BACKGROUND:

Multiple nonpharmaceutical interventions (NPIs) had been introduced in Hong Kong during coronavirus disease 2019 (COVID-19) pandemic. The impact on asthma admission, which was closely related to viral infection, was of concern.

OBJECTIVE:

The study aimed to identify the impact of NPIs on pediatric asthma admissions and their association with respiratory viruses.

METHODS:

We conducted a retrospective observational study to compare the difference in pediatric asthma hospital admission rates between pre-COVID-19 and COVID-19 periods. Information on demographics, nasopharyngeal specimen results, ventilatory support, intensive care admission, hospital stay duration, asthma control therapy, and previous admission episodes was collected. Weather parameters including temperature, rainfall, humidity, and air quality data that was reflected by the air quality health index were recorded.

RESULTS:

A total of 1808 pediatric asthma admissions were recorded during the pre-COVID-19 period while there were 62 admissions during COVID-19 period, among which 54 admissions from the pre-COVID-19 period and 4 admissions from COVID-19 period were excluded. Weekly pediatric asthma admissions per total pediatric admissions during COVID-19 was one-third of that during the pre-COVID-19 period (0.3% vs. 0.9%, p < 0.001). During COVID-19 period, a significantly lower percentage of respiratory virus isolates was noted (58.6% vs. 72.6%, p = 0.019). Poisson regression analysis showed that the COVID-19 period (odds ratio [OR] = 0.202, 95% confidence interval  [CI, 0.16-0.26]; p ≤ 0.001), summer vacation period (OR = 0.512, 95% CI [0.43-0.62]; p ≤ 0.001), and humidity (OR = 0.99, 95% CI [0.98-1.00]; p = 0.004) were independent protective factors for asthma admission.

CONCLUSIONS:

There was a significant reduction in pediatric asthma hospitalizations and respiratory virus isolates in the first year of COVID-19 pandemic in Hong Kong with the implementation of NPIs. Rhinovirus remained the key respiratory virus isolate. Incorporation of appropriate NPIs in long run could reduce virus infection-related pediatric asthma admission.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / COVID-19 Type of study: Etiology study / Observational study / Prognostic study Limits: Child / Humans Country/Region as subject: Asia Language: English Journal: Pediatr Pulmonol Journal subject: Pediatrics Year: 2022 Document Type: Article Affiliation country: Ppul.26141

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / COVID-19 Type of study: Etiology study / Observational study / Prognostic study Limits: Child / Humans Country/Region as subject: Asia Language: English Journal: Pediatr Pulmonol Journal subject: Pediatrics Year: 2022 Document Type: Article Affiliation country: Ppul.26141